The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development of a circulating tumor cell-based RNA classifier for patients with castration-resistant prostate cancer: CTC-PCS/PAM50.
 
Pai-Chi Teng
No Relationships to Disclose
 
Yu Jen Jan
No Relationships to Disclose
 
Minhyung Kim
No Relationships to Disclose
 
Jie-Fu Chen
No Relationships to Disclose
 
Junhee Yoon
No Relationships to Disclose
 
Jasmine Jiemei Wang
No Relationships to Disclose
 
Pin-Jung Chen
No Relationships to Disclose
 
Nu Yao
No Relationships to Disclose
 
Yi-Te Lee
No Relationships to Disclose
 
Amber Lozano
No Relationships to Disclose
 
Ruslan Gadilov
No Relationships to Disclose
 
Michael Freeman
No Relationships to Disclose
 
Sungyong You
No Relationships to Disclose
 
Hsian-Rong Tseng
Patents, Royalties, Other Intellectual Property - Patent on NanoVelcro assay for purification of circulating tumor cells
Other Relationship - CytoLumina
 
Edwin Melencio Posadas
Consulting or Advisory Role - CytoLumina; Genentech/Roche; Janssen Oncology; Janssen Oncology; Novartis
Speakers' Bureau - Bayer
Research Funding - PFizer
Patents, Royalties, Other Intellectual Property - Patent on NanoVelcro Assay for CTCs in prostate cancer
Travel, Accommodations, Expenses - TRACON Pharma